Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Ann Thorac Surg. 2012 Dec 13;95(2):570–577. doi: 10.1016/j.athoracsur.2012.10.084

Fig 4.

Fig 4

Increased degradation of versican in aortic aneurysm and dissection tissues. (A) Western blot and quantitative analysis of versican degradation products in control, thoracic aortic aneurysm (TAA), and thoracic aortic dissection (TAD) tissues. (B) Correlation between versican degradation and levels of ADAMTS-1 and ADAMTS-4 protein. (C) Quantitative real-time PCR analysis of versican V0 mRNA levels in control, TAA, and TAD tissues.